TCF7L2 and cancer: To evaluate T-cep, we applied it on TCF7L2-omics data, including ChIP-seq data of TCF7L2, Pol-II, active chromatin marks (H3K4me1,3 and H3K27ac), repressive chromatin marks (H3K27me3 and H3K9me3), a mark of transcriptional elongation (H3K36me3) as well as DNase-seq for open chromatin regions in five cancer cell types.